<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Parkman HP</submitter><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>e14087</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8310540</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(8)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Understanding factors that impair quality of life (QOL) in gastroparesis is important for clinical management.&lt;h4>Aims&lt;/h4>(a) Determine QOL in patients with gastroparesis; (b) Determine factors that impair QOL.&lt;h4>Methods&lt;/h4>Gastroparetic patientsAQ6 underwent history and questionnaires assessing symptoms (PAGI-SYM and Rome III), QOL (SF-36v2 and PAGI-QOL), depression (Beck Depression Inventory [BDI]), and anxiety (State Trait Anxiety InventoryAQ7).&lt;h4>Key results&lt;/h4>715 gastroparesis patients (256 diabetic (DG), 459 idiopathic (IG)) were evaluated. SF-36 physical component (PC) score averaged 33.3 ± 10.5; 41% had impaired score &lt;30. SF-36 PC scores were similar between diabetic and idiopathic gastroparesis. Impaired SF-36 PC associated with increased nausea/vomiting and upper abdominal pain subscores, acute onset of symptoms, higher number of comorbidities, use of narcotic pain medications, and irritable bowel syndrome (IBS). SF-36 mental component (MC) score averaged 38.9 ± 13.0; 26% had impaired score &lt;30. Poor SF-36 MC associated with diabetic etiology, higher Beck depression inventory, and state anxiety scores. PAGI-QOL score averaged 2.6 ± 1.1; 50% had a score of &lt;2.6. Low PAGI-QOL associated with higher fullness, bloating, and upper abdominal pain subscores, more depression and Trait anxiety, smoking cigarettes, need for nutritional support, progressively worsening symptoms and periodic exacerbations.&lt;h4>Conclusions &amp; inferences&lt;/h4>Multiple measures show poor QOL present in gastroparesis. Several areas impacted on reduced QOL: (a) Symptoms of nausea, vomiting, and abdominal pain, as well as IBS; (b) Etiology and acute onset and progressively worsening symptoms; (c) Comorbidities and psychological factors such as anxiety and depression; (d) Patient-related factors such as smoking. Targeting the modifiable factors may improve patient outcomes in gastroparesis.</pubmed_abstract><journal>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society</journal><pubmed_title>Factors that contribute to the impairment of quality of life in gastroparesis.</pubmed_title><pmcid>PMC8310540</pmcid><funding_grant_id>U01 DK112193</funding_grant_id><funding_grant_id>U01DK112193</funding_grant_id><funding_grant_id>U01DK112194</funding_grant_id><funding_grant_id>U01 DK112194</funding_grant_id><funding_grant_id>U24DK074008</funding_grant_id><funding_grant_id>U01DK073975</funding_grant_id><funding_grant_id>U01DK074008</funding_grant_id><funding_grant_id>U24 DK074008</funding_grant_id><funding_grant_id>U01 DK074035</funding_grant_id><funding_grant_id>U01 DK073975</funding_grant_id><funding_grant_id>U01 DK074008</funding_grant_id><funding_grant_id>U01DK074035</funding_grant_id><funding_grant_id>U01 DK073983</funding_grant_id><funding_grant_id>U01DK073983</funding_grant_id><funding_grant_id>U01 DK074007</funding_grant_id><funding_grant_id>U01DK074007</funding_grant_id><funding_grant_id>U01 DK073974</funding_grant_id><funding_grant_id>U01DK073974</funding_grant_id><pubmed_authors>Schey R</pubmed_authors><pubmed_authors>McCallum RW</pubmed_authors><pubmed_authors>Tonascia J</pubmed_authors><pubmed_authors>Hamilton F</pubmed_authors><pubmed_authors>Pasricha PJ</pubmed_authors><pubmed_authors>NIDDK/NIH Clinical Gastroparesis Consortium</pubmed_authors><pubmed_authors>Miriel L</pubmed_authors><pubmed_authors>Yates KP</pubmed_authors><pubmed_authors>Kuo B</pubmed_authors><pubmed_authors>Parkman HP</pubmed_authors><pubmed_authors>Wilson LA</pubmed_authors><pubmed_authors>Koch KL</pubmed_authors><pubmed_authors>Abell TL</pubmed_authors><pubmed_authors>Shulman RJ</pubmed_authors><pubmed_authors>Sarosiek I</pubmed_authors><pubmed_authors>Malik Z</pubmed_authors><pubmed_authors>Grover M</pubmed_authors><pubmed_authors>Farrugia G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Factors that contribute to the impairment of quality of life in gastroparesis.</name><description>&lt;h4>Background&lt;/h4>Understanding factors that impair quality of life (QOL) in gastroparesis is important for clinical management.&lt;h4>Aims&lt;/h4>(a) Determine QOL in patients with gastroparesis; (b) Determine factors that impair QOL.&lt;h4>Methods&lt;/h4>Gastroparetic patientsAQ6 underwent history and questionnaires assessing symptoms (PAGI-SYM and Rome III), QOL (SF-36v2 and PAGI-QOL), depression (Beck Depression Inventory [BDI]), and anxiety (State Trait Anxiety InventoryAQ7).&lt;h4>Key results&lt;/h4>715 gastroparesis patients (256 diabetic (DG), 459 idiopathic (IG)) were evaluated. SF-36 physical component (PC) score averaged 33.3 ± 10.5; 41% had impaired score &lt;30. SF-36 PC scores were similar between diabetic and idiopathic gastroparesis. Impaired SF-36 PC associated with increased nausea/vomiting and upper abdominal pain subscores, acute onset of symptoms, higher number of comorbidities, use of narcotic pain medications, and irritable bowel syndrome (IBS). SF-36 mental component (MC) score averaged 38.9 ± 13.0; 26% had impaired score &lt;30. Poor SF-36 MC associated with diabetic etiology, higher Beck depression inventory, and state anxiety scores. PAGI-QOL score averaged 2.6 ± 1.1; 50% had a score of &lt;2.6. Low PAGI-QOL associated with higher fullness, bloating, and upper abdominal pain subscores, more depression and Trait anxiety, smoking cigarettes, need for nutritional support, progressively worsening symptoms and periodic exacerbations.&lt;h4>Conclusions &amp; inferences&lt;/h4>Multiple measures show poor QOL present in gastroparesis. Several areas impacted on reduced QOL: (a) Symptoms of nausea, vomiting, and abdominal pain, as well as IBS; (b) Etiology and acute onset and progressively worsening symptoms; (c) Comorbidities and psychological factors such as anxiety and depression; (d) Patient-related factors such as smoking. Targeting the modifiable factors may improve patient outcomes in gastroparesis.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2024-11-14T01:21:57.142Z</modification><creation>2022-02-11T09:02:02.565Z</creation></dates><accession>S-EPMC8310540</accession><cross_references><pubmed>33493377</pubmed><doi>10.1111/nmo.14087</doi></cross_references></HashMap>